JP2004533415A5 - - Google Patents

Download PDF

Info

Publication number
JP2004533415A5
JP2004533415A5 JP2002567288A JP2002567288A JP2004533415A5 JP 2004533415 A5 JP2004533415 A5 JP 2004533415A5 JP 2002567288 A JP2002567288 A JP 2002567288A JP 2002567288 A JP2002567288 A JP 2002567288A JP 2004533415 A5 JP2004533415 A5 JP 2004533415A5
Authority
JP
Japan
Prior art keywords
composition
formula
enantiomer
phenyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002567288A
Other languages
English (en)
Japanese (ja)
Other versions
JP4276837B2 (ja
JP2004533415A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from US10/081,766 external-priority patent/US6562867B2/en
Publication of JP2004533415A publication Critical patent/JP2004533415A/ja
Publication of JP2004533415A5 publication Critical patent/JP2004533415A5/ja
Application granted granted Critical
Publication of JP4276837B2 publication Critical patent/JP4276837B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002567288A 2001-02-27 2002-02-21 双極性障害の予防もしくは治療における使用のためのカルバメート化合物 Expired - Lifetime JP4276837B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27168101P 2001-02-27 2001-02-27
US10/081,766 US6562867B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder
PCT/US2002/005297 WO2002067921A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder

Publications (3)

Publication Number Publication Date
JP2004533415A JP2004533415A (ja) 2004-11-04
JP2004533415A5 true JP2004533415A5 (cg-RX-API-DMAC7.html) 2005-12-22
JP4276837B2 JP4276837B2 (ja) 2009-06-10

Family

ID=26765948

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002567288A Expired - Lifetime JP4276837B2 (ja) 2001-02-27 2002-02-21 双極性障害の予防もしくは治療における使用のためのカルバメート化合物

Country Status (26)

Country Link
US (1) US6562867B2 (cg-RX-API-DMAC7.html)
EP (1) EP1408953B1 (cg-RX-API-DMAC7.html)
JP (1) JP4276837B2 (cg-RX-API-DMAC7.html)
KR (1) KR100946944B1 (cg-RX-API-DMAC7.html)
CN (1) CN1250215C (cg-RX-API-DMAC7.html)
AT (1) ATE324108T1 (cg-RX-API-DMAC7.html)
BR (1) BR0207644A (cg-RX-API-DMAC7.html)
CA (1) CA2439475C (cg-RX-API-DMAC7.html)
CY (1) CY1105330T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20032300A3 (cg-RX-API-DMAC7.html)
DE (1) DE60210976T2 (cg-RX-API-DMAC7.html)
DK (1) DK1408953T3 (cg-RX-API-DMAC7.html)
ES (1) ES2262801T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0303243A3 (cg-RX-API-DMAC7.html)
IL (1) IL157590A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03007717A (cg-RX-API-DMAC7.html)
MY (1) MY129304A (cg-RX-API-DMAC7.html)
NO (1) NO20033802L (cg-RX-API-DMAC7.html)
NZ (1) NZ527988A (cg-RX-API-DMAC7.html)
PL (1) PL364638A1 (cg-RX-API-DMAC7.html)
PT (1) PT1408953E (cg-RX-API-DMAC7.html)
RS (1) RS50677B (cg-RX-API-DMAC7.html)
RU (1) RU2300372C2 (cg-RX-API-DMAC7.html)
TW (1) TWI250872B (cg-RX-API-DMAC7.html)
WO (1) WO2002067921A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200307465B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ523851A (en) * 2000-07-21 2004-09-24 Ortho Mcneil Pharm Inc A method for use of carbamate enantiomers in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
WO2002067923A1 (en) * 2001-02-27 2002-09-06 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating anxiety disorders
PT1383489E (pt) * 2001-02-27 2007-06-21 Ortho Mcneil Pharm Inc Compostos carbamato para utilização na prevenção ou tratamento de distúrbios neurodegenerativos
BR0211244A (pt) 2001-07-16 2004-07-27 Ortho Mcneil Pharm Inc Compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada com cefaléia em salvas e enxaqueca
NZ553813A (en) * 2004-09-16 2010-09-30 Janssen Pharmaceutica Nv Use of 2-phenyl-1, 2-ethanediol-(DI) carbamates for treating epileptogenesis and epilepsy
KR101335941B1 (ko) 2005-06-08 2013-12-04 에스케이바이오팜 주식회사 수면-각성 장애의 치료
US20070021501A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods of treating epileptogenesis
BRPI0718324A2 (pt) * 2006-10-30 2013-11-26 Sk Holdings Métodos para o tratamento de depressão.
CN101568333A (zh) * 2006-10-31 2009-10-28 詹森药业有限公司 广泛性发育障碍的治疗
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
KR102014615B1 (ko) * 2013-03-12 2019-08-27 (주)바이오팜솔루션즈 페닐카바메이트 화합물 및 이를 포함하는 신경보호용 조성물
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
KR102635938B1 (ko) * 2016-12-14 2024-02-13 에스케이바이오팜 주식회사 양극성 장애의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도
BR112019025286A2 (pt) 2017-06-02 2020-06-23 Jazz Pharmaceuticals Ireland Limited Métodos e composições para tratamento de sonolência excessiva
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
CN1056611C (zh) * 1994-06-16 2000-09-20 美国辉瑞有限公司 吡唑并吡啶和吡咯并吡啶,其用途和用于制备它们的中间体
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Similar Documents

Publication Publication Date Title
JP2004525905A5 (cg-RX-API-DMAC7.html)
JP2004533415A5 (cg-RX-API-DMAC7.html)
JP2004527492A5 (cg-RX-API-DMAC7.html)
JP2006526590A5 (cg-RX-API-DMAC7.html)
JP2009531376A5 (cg-RX-API-DMAC7.html)
JP2007511504A5 (cg-RX-API-DMAC7.html)
JP2010502730A5 (cg-RX-API-DMAC7.html)
RU2003128984A (ru) Производные карбаматов для использования для лечения боли
JP2011519865A5 (cg-RX-API-DMAC7.html)
JP2006504738A5 (cg-RX-API-DMAC7.html)
JPWO2023195529A5 (cg-RX-API-DMAC7.html)
JP2002527414A5 (cg-RX-API-DMAC7.html)
RU2003128996A (ru) Карбаматы для применения для предотвращения или лечения биполярного расстройства
JP2004529114A5 (cg-RX-API-DMAC7.html)
CA2439475A1 (en) Carbamate compounds for use in preventing or treating bipolar disorder
JP2004523556A5 (cg-RX-API-DMAC7.html)
BR0112713A (pt) "compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada a cefaléia em cacho e hemicrânia
RU2003128983A (ru) Производные карбаматов для предотвращения или лечения психотических нарушений
JP2004521126A5 (cg-RX-API-DMAC7.html)
CA2523253A1 (en) Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists
JP2013507438A5 (cg-RX-API-DMAC7.html)
JP2006520807A5 (cg-RX-API-DMAC7.html)
JP2005516952A5 (cg-RX-API-DMAC7.html)
JP2005529110A5 (cg-RX-API-DMAC7.html)
JP2004528311A5 (cg-RX-API-DMAC7.html)